Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While Ocugen (NASDAQ: OCGN ) stock is up over 200% this year, it hasn’t been a case of slow and steady growth. On two separate occasions, the shares have been much higher. Yet when I wrote about ...
BRYAN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that management will present an update on the Company’s business at ...
Even though biotechnology company iBio (IBIO) reported some positive developments related to its COVID-19 vaccine candidates this month, it is way behind competitors that are already distributing COVID-19 vaccines. So, will it's FastPharming System give it a late edge over its peers? Read on....
iBio, Inc. (IBIO) Q3 2021 Results Earnings Conference Call May 17, 2021, 08:00 AM ET Company Participants Stephen Kilmer - Investor Relations Thomas Isett - Chairman & Chief Executive Officer Robert Lutz - Chief Financial and Business Officer Conference Call Participants Kristen Kluska - ...
iBio (IBIO) saw its Q1 net loss increase ~64% to $7.7M ($0.04 per share) year-over-year as the plant-based biologics manufacturing company saw its expenses drastically increase.Revenue for the quarter increased 700% compared to Q1 2020 to $800M and FQ3 GAAP EPS was -$0.04.Gross profit in the ...
iBio (IBIO): FQ3 GAAP EPS of -$0.04.Revenue of $0.8M (+700.0% Y/Y) in-line.Cash, cash equivalents and debt investments of $103.9M. The Company believes it will have sufficient resources to fund its planned operations at least through March 31, 2023, inclusive of its planned investment in the&...
BRYAN, Texas., May 17, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended March 31, 2021. ...
Are These the Best Biotech Penny Stocks Today? We’ve been covering the trend of biotech penny stocks for quite some time. And, with social media sites like Reddit only helping to push this industry up, the challenge to find the best ones is palpable. Many find it difficult to mak...
BRYAN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will report its fiscal 2021 third quarter financial results before...
Shares of iBio (NYSEMKT: IBIO) climbed on Friday after the biotech announced plans to develop an intriguing second-generation vaccine candidate for COVID-19. By the close of trading, iBio's stock price was up 16.7% after rising as much as 41.3% earlier in the day. iBio's exp...
News, Short Squeeze, Breakout and More Instantly...
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
2024-05-28 07:30:05 ET Chardan Capital analyst issues BUY recommendation for IBIO on May 28, 2024 05:34AM ET. IBIO was trading at $2.19 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommenda...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...